Evidence map›Paper›PMID 28961222›Full record

ArticleNanomaterials (Basel, Switzerland)2017

Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification.

Francesca Alessandrini, Antje Vennemann, Silvia Gschwendtner, Avidan U Neumann, Michael Rothballer, Tanja Seher, Maria Wimmer, Susanne Kublik, Claudia Traidl-Hoffmann, Michael Schloter and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Eosinophils and Lung Mucosal Antibody Production: Is Location the Key?American journal of respiratory cell and molecular biology · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Role ofArchives of Razi Institute · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Metal-Based Nanoparticles as Antimicrobial Agents: An Overview.Nanomaterials (Basel, Switzerland) · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Francesca AlessandriniCenter of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. franci@helmholtz-muenchen.de.
Antje VennemannIBE R & D Institute for Lung Health gGmbH, Mendelstr. 11, 48149 Münster, Germany. vennemann@ibe-ms.de.
Silvia GschwendtnerResearch Unit for Comparative Microbiome Analysis, Helmholtz Center Munich, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. silvia.gschwendtner@helmholtz-muenchen.de.
Avidan U NeumannChair and Institute of Environmental Medicine, UNIKA-T, Technical University of Munich and Helmholtz Center Munich, ,Neusäßer Str. 17, 86156 Augsburg, Germany. auneumann@gmail.com.
Michael RothballerInstitute of Network Biology (INET), Helmholtz Center Munich, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. rothballer@helmholtz-muenchen.de.ORCID 0000-0003-4881-2705
Tanja SeherCenter of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. tanja.seher@helmholtz-muenchen.de.
Maria WimmerCenter of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. maria.wimmer84@web.de.
Susanne KublikResearch Unit for Comparative Microbiome Analysis, Helmholtz Center Munich, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. susanne.kublik@helmholtz-muenchen.de.
Claudia Traidl-HoffmannChair and Institute of Environmental Medicine, UNIKA-T, Technical University of Munich and Helmholtz Center Munich, ,Neusäßer Str. 17, 86156 Augsburg, Germany. claudia.traidl-hoffmann@tum.de.
Michael SchloterResearch Unit for Comparative Microbiome Analysis, Helmholtz Center Munich, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. schloter@helmholtz-muenchen.de.
Martin WiemannIBE R & D Institute for Lung Health gGmbH, Mendelstr. 11, 48149 Münster, Germany. martin.wiemann@ibe-ms.de.
Carsten B Schmidt-WeberCenter of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. csweber@tum.de.
German Center for Lung Research · DEHelmholtz Zentrum München · DECK-CARE · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supernatants from (5.6-45 µg/mL) Ag50-PVP, Ag200-PVP or Ag50-citrate-treated NR8383 alveolar macrophages were tested for lactate dehydrogenase and glucuronidase activity, tumor necrosis factor (TNF)-α release and reactive oxygen species (ROS) production. For the in vivo study, NPs were intratracheally instilled in non-sensitized (NS) and OVA-sensitized (S) mice (1-50 µg/mouse) prior to OVA-challenge and bronchoalveolar lavage fluid (BALF) inflammatory infiltrate was evaluated five days after challenge. In vitro results showed a dose-dependent cytotoxicity of Ag-NPs, which was highest for Ag50-polyvinilpyrrolidone (PVP), followed by Ag50-citrate, and lowest for Ag200-PVP. In vivo 10-50 µg Ag50-PVP triggered a dose-dependent pulmonary inflammatory milieu in NS and S mice, which was significantly higher in S mice and was dampened upon instillation of Ag200-PVP. Surprisingly, instillation of 1 µg Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in S mice and had no adverse effect in NS mice. Ag50-citrate showed similar beneficial effects at low concentrations and attenuated pro-inflammatory effects at high concentrations. The lung microbiome was altered by NPs instillation dependent on coating and/or mouse batch, showing the most pronounced effects upon instillation of 50 µg Ag50-citrate, which caused an increased abundance of operational taxonomic units assigned to Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. However, no correlation with the biphasic effect of low and high Ag-NPs dose was found. Altogether, both in vitro and in vivo data on the pulmonary effects of Ag-NPs suggest the critical role of the size, dose and surface functionalization of Ag-NPs, especially in susceptible allergic individuals. From the perspective of occupational health, care should be taken by the production of Ag-NPs-containing consumer products.

Indexed as

adjuvantallergic inflammationsilver nanoparticlessurface modification

Identifiers

PMID28961222
PMCPMC5666465
OpenAlexW2759553462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.